HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel J George Selected Research

Biological Products

3/2021Differences in Toxicity and Outcomes in Clinical Trial Participants From Minority Populations.
4/2016Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
10/2005Targeted therapy in renal cell carcinoma.
9/2004Tyrosine kinase inhibitors in renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel J George Research Topics

Disease

104Prostatic Neoplasms (Prostate Cancer)
04/2022 - 09/2002
73Neoplasms (Cancer)
10/2022 - 01/2002
68Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 01/2002
25Disease Progression
01/2022 - 06/2005
20Neoplasm Metastasis (Metastasis)
04/2022 - 11/2007
12Circulating Neoplastic Cells
10/2022 - 08/2011
9Carcinoma (Carcinomatosis)
12/2020 - 02/2002
9Pain (Aches)
01/2017 - 03/2007
7Kidney Neoplasms (Kidney Cancer)
01/2021 - 07/2003
4Hypertension (High Blood Pressure)
03/2021 - 03/2016
4Fatigue
10/2020 - 10/2008
4Hypoxia (Hypoxemia)
01/2017 - 09/2004
3Inflammation (Inflammations)
01/2017 - 09/2014
3Thrombocytopenia (Thrombopenia)
01/2017 - 01/2005
3Neutropenia
01/2017 - 06/2006
3Diarrhea
01/2017 - 10/2008
2Anemia
10/2020 - 06/2006
2Breast Neoplasms (Breast Cancer)
01/2020 - 08/2011
2Cancer Pain
09/2013 - 01/2013
2Headache (Headaches)
09/2011 - 10/2008

Drug/Important Bio-Agent (IBA)

26Sunitinib (Sutent)FDA Link
10/2021 - 01/2006
24Biomarkers (Surrogate Marker)IBA
10/2022 - 06/2004
17AndrogensIBA
01/2022 - 02/2002
17Hormones (Hormone)IBA
12/2021 - 06/2004
16enzalutamideIBA
04/2022 - 03/2015
16EverolimusFDA Link
10/2021 - 11/2010
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 09/2002
14Prostate-Specific Antigen (Semenogelase)IBA
12/2021 - 02/2002
14Docetaxel (Taxotere)FDA Link
11/2019 - 01/2005
13Abiraterone AcetateIBA
04/2022 - 01/2013
12Prednisone (Sone)FDA LinkGeneric
12/2021 - 01/2013
11cabozantinibIBA
09/2021 - 10/2014
10abirateroneIBA
01/2022 - 01/2013
10Tyrosine Kinase InhibitorsIBA
01/2021 - 09/2004
9Radium-223IBA
01/2022 - 01/2013
9Immune Checkpoint InhibitorsIBA
02/2021 - 01/2018
9sipuleucel-T (APC8015)FDA Link
12/2019 - 01/2011
9Pharmaceutical PreparationsIBA
01/2019 - 09/2002
8Androgen Receptors (Androgen Receptor)IBA
01/2022 - 03/2005
7NivolumabIBA
01/2022 - 01/2018
7Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2019 - 09/2002
7TOR Serine-Threonine KinasesIBA
08/2015 - 06/2010
6Bevacizumab (Avastin)FDA Link
01/2022 - 08/2008
6Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2003
5pazopanibFDA Link
01/2021 - 09/2014
5Sorafenib (BAY 43-9006)FDA Link
11/2015 - 03/2007
5temsirolimusFDA Link
07/2015 - 12/2013
4taxaneIBA
01/2022 - 06/2005
4IpilimumabIBA
01/2022 - 01/2021
4Testosterone (Sustanon)FDA Link
12/2021 - 01/2020
4Biological ProductsIBA
03/2021 - 09/2004
4RNA (Ribonucleic Acid)IBA
10/2020 - 12/2013
4Mechanistic Target of Rapamycin Complex 1IBA
01/2020 - 06/2010
4Alkaline PhosphataseIBA
10/2019 - 09/2015
4Narcotics (Narcotic Analgesics)IBA
02/2015 - 03/2007
4Phosphotransferases (Kinase)IBA
10/2014 - 09/2002
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2007 - 09/2002
3Peptides (Polypeptides)IBA
10/2022 - 02/2004
3Disulfiram (Antabuse)FDA Link
01/2022 - 10/2014
3CopperIBA
01/2022 - 10/2014
3ProdrugsIBA
01/2020 - 01/2017
3Hemoglobins (Hemoglobin)IBA
10/2019 - 09/2015
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2017 - 09/2012
3CytokinesIBA
11/2016 - 01/2007
2Antineoplastic Agents (Antineoplastics)IBA
10/2022 - 01/2021
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 10/2020
2B7-H1 AntigenIBA
12/2021 - 10/2019
2antiarrhythmic peptide (AAP)IBA
12/2021 - 01/2021
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2021 - 01/2020
2relugolixIBA
11/2021 - 01/2020
2angiokinesIBA
06/2021 - 01/2021
2LigandsIBA
02/2021 - 03/2005
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021 - 03/2013
2Interleukin-2 (IL2)IBA
01/2021 - 09/2004
2AntigensIBA
10/2020 - 12/2016
2pembrolizumabIBA
10/2020 - 01/2019
2PlatinumIBA
10/2020 - 10/2007
2Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link
01/2020 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 12/2003
2Cell-Free Nucleic AcidsIBA
01/2020 - 11/2016
2Messenger RNA (mRNA)IBA
01/2019 - 06/2003
2Sirolimus (Rapamycin)FDA Link
10/2018 - 06/2010
2Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
01/2017 - 12/2013
2Opiate AlkaloidsIBA
01/2017 - 01/2013
2Monoclonal AntibodiesIBA
12/2016 - 03/2013
2MTOR InhibitorsIBA
11/2014 - 08/2014
2tyrosine receptor (receptor, tyrosine)IBA
10/2014 - 09/2002
2Analgesics (Analgesic Drugs)IBA
10/2014 - 09/2013
2AtrasentanIBA
05/2014 - 10/2008
2Zoledronic Acid (Zometa)FDA Link
12/2013 - 01/2013
2Tyrosine (L-Tyrosine)FDA Link
01/2013 - 03/2007
2EnzymesIBA
09/2012 - 02/2004

Therapy/Procedure

74Therapeutics
04/2022 - 09/2002
58Castration
04/2022 - 05/2008
28Immunotherapy
10/2022 - 02/2004
23Drug Therapy (Chemotherapy)
04/2022 - 01/2005
7Prostatectomy (Retropubic Prostatectomy)
12/2021 - 02/2004
6Nephrectomy
02/2020 - 10/2007
5Radiotherapy
12/2021 - 03/2007
4Aftercare (After-Treatment)
01/2022 - 09/2011